USPTO serial 79005095
LEMNAGENE
Reviewed by CopyMark Law Group
Reg. 3133211Status 404
- Filing date
- Status date
- Registration date
- Aug 22, 2006
- Examiner
- KRISP, JENNIFER MARIE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with LEMNAGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
F-69450 SAINT-CYR-AU-MONT-D'OR, FR
F-69450 SAINT-CYR-AU-MONT-D'OR, FR
F-69450 SAINT-CYR-AU-MONT-D'OR, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
MARY MARGARET L ODONNELL RADER FISHMAN & GRAUER PLLC39533 WOODWARD AVE STE 140BLOOMFIELD HILLS, MI 48304UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical products for use in industry, in the agri-food industry, in the agriculture industry, science, horticulture and forestry, namely, synthetic organic raw materials and synthetic agents, namely, industrial nitrocelluloses in form of collodion solution or in form of chips, benzyl chloroformate in liquid form, methyl-cyclohexyl acetate in liquid form; biological preparations not for medical or veterinary use, namely biological preparations destined for biomedical research, namely, vaccines, antibiotics, medicinal creams | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical and veterinary products in the form of tablets, liquids to be administered by injection, liquids to be taken orally for the treatment of infectious diseases, viruses, immunodeficiency, transplants, cancer, sclerosis, auto-immune disorders, cardio-vascular disorders; chemical preparations for medical or pharmaceutical purposes, chemical preparations for veterinary purposes; medicines for human purposes, namely, ophthalmic gels, growth factors, cytokines, therapeutic proteins, monoclonal antibodies for the treatment of infectious diseases, immunodeficiency, transplants, cancer, sclerosis, auto-immune disorders, cardio-vascular disorders; medicines for veterinary purposes, namely, antibiotics, vaccines, antiseptic solutions, disinfectant solutions; therapeutic preparations, namely, tablets, capsules, powders, gelcaps, bars and liquid extracts containing concentrated extracts of vitamins, protein, enzymes for the treatment of infectious disease, viruses, immunodeficiency, transplants, cancer, sclerosis, auto-immune disorders, cardio-vascular disorders; vaccines; biological preparations for medical purposes; cultures of microorganisms for medical or veterinary purposes | SECTION 71 - CANCELLED | — |
| 042 | Evaluations, assessments and research in the fields of medical science and pharmaceutical technology provided by engineers; chemical research, biological research, bacteriological research, cosmetic science research, chemical analyses, physics research, clinical studies, research in biotechnology | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LEMNAGENE S.A.
- Other trademarks owned by LEMNAGENE S.A.
- Other trademarks owned by LEMNAGENE S.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named LEMNAGENE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 22, 2015 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Jan 22, 2015 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Dec 5, 2014 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 28, 2014 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 30, 2014 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 30, 2013 | C71T | CANCELLED SECTION 71 | — |
| Apr 18, 2008 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 14, 2007 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 14, 2007 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 10, 2007 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 22, 2006 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 30, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 10, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 12, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 12, 2006 | ALIE | ASSIGNED TO LIE | — |
| Apr 6, 2006 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 24, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 16, 2006 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 16, 2006 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 6, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 27, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 27, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 26, 2005 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 26, 2005 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 12, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 4, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 4, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2005 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 4, 2005 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 10, 2005 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 8, 2005 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2005 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2005 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 15, 2004 | NWAP | NEW APPLICATION ENTERED | — |
| Oct 14, 2004 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |